3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Promyelocytic, Acute
5
Thrombocytopenia
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Primary Myelofibrosis
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Oligometastatic Disease
1
Oligodendroglioma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Glioma
1
Interventions
ribociclib
1
Tretinoin
1
Letrozole
1
Goserelin
1
Drug Therapy
1
Chemotherapy, Adjuvant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HER2 Negative Breast Cancer
×
Tretinoin
×
1 year
×
Clear all
NCT06731140
2025-11-17
Resilire
Fudan University
Phase 2
Recruiting
10 enrolled